Cart
sales@molnova.com
Cibisatamab
CAS No. 1855925-27-7
Cibisatamab( —— )
Catalog No. M36660 CAS No. 1855925-27-7
Cibisatamab is a T-cell bispecific antibody that acts as a T-cell splicer.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 854 | Get Quote |
|
| 5MG | 943 | Get Quote |
|
| 10MG | 1568 | Get Quote |
|
| 25MG | 2263 | Get Quote |
|
| 50MG | 3054 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCibisatamab
-
NoteResearch use only, not for human use.
-
Brief DescriptionCibisatamab is a T-cell bispecific antibody that acts as a T-cell splicer.
-
DescriptionCibisatamab (CEA-TCB), a T cell bispecific antibody, binds Carcino-Embryonic Antigen (CEA) on cancer cells and CD3 on T cells. Cibisatamab (CEA-TCB) triggers T cell killing of cancer cell lines expressing moderate to high levels of CEA at the cell surface. Cibisatamab (CEA-TCB) can be used for colorectal cancer research.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1855925-27-7
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Reyes Gonzalez-Exposito, et al. CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids. J Immunother Cancer. 2019 Apr 15;7(1):101. ?
molnova catalog
related products
-
Caulilexin C
Caulilexin C shows inhibitory activity on human Acyl CoA: cholesterol transferase I (hACATI) and on human Acyl CoA: cholesterol transferase 2 (hACAT2) at 100 mug/ml.
-
Cyclo(L-Phe-L-Pro)
Cyclo(L-Phe-L-Pro) shows broad-spectrum antibacterial and antifungal activities. Cyclo(L-Phe-L-Pro) exhibits activity against methicillin-resistant S. aureus and Enterococcus raffinosus.
-
TASIN-1
TASIN-1 is a small molecule inhibitor of mutant adenomatous polyposis coli (APC).
